Antimicrobial Resistance with Streptococcus pneumoniae in the United States, 1997–98

From November 1997 to April 1998, 1,601 clinical isolates of Streptococcus pneumoniae were obtained from 34 U.S. medical centers. The overall rate of strains showing resistance to penicillin was 29. 5%, with 17.4% having intermediate resistance. Multidrug resistance, defined as lack of susceptibility to penicillin and at least two other non-ss-lactam classes of antimicrobial drugs, was observed in 16.0% of isolates. Resistance to all 10 ss-lactam drugs examined in this study was directly related to the level of penicillin resistance. Penicillin resistance rates were highest in isolates from middle ear fluid and sinus aspirates of children ambulatory-care settings. Twenty-four of the 34 medical centers in this study had participated in a similar study 3 years before. In 19 of these 24 centers, penicillin resistance rates increased 2.9% to 39.2%. Similar increases were observed with rates of resistance to other antimicrobial drugs.

1. 1.

   Barry A. L., Pfaller M. A., Fuchs P. C., Packer R. R. In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993. Antimicrob Agents Chemother. 1994;38(10):2419-2425.

   Not in our library10.1128/aac.38.10.2419 (opens in a new tab)

2. 2.

   Doern G. V., Pfaller M. A., Kugler K., Freeman J., Jones R. N. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program. Clin Infect Dis. 1998;27(4):764-770.

   Not in our library10.1086/514953 (opens in a new tab)

3. 3.

   Hill H. W. The Saloon and the Health Officer. Am J Public Hygiene. 1910;20(1):5.1-7.1.

   Not in our library

4. 4.

   Houston B. K., Babyak M. A., Chesney M. A., Black G., Ragland D. R. Social dominance and 22-year all-cause mortality in men. Psychosom Med. 1997;59(1):5-12.

   Not in our library10.1097/00006842-199701000-00002 (opens in a new tab)

5. 5.

   Jamin M., Hakenbeck R., Frere J. M. Penicillin binding protein 2x as a major contributor to intrinsic beta-lactam resistance of Streptococcus pneumoniae. FEBS Lett. 1993;331(1-2):101-104.

   Not in our library10.1016/0014-5793(93)80305-e (opens in a new tab)

6. 6.

   Jones R. N., Pfaller M. A., Doern G. V. Comparative antimicrobial activity of trovafloxacin tested against 3049 Streptococcus pneumoniae isolates from the 1997-1998 respiratory infection season. Diagn Microbiol Infect Dis. 1998;32(2):119-126.

   Not in our library10.1016/s0732-8893(98)00072-8 (opens in a new tab)

7. 7.

   Jorgensen J. H., Doern G. V., Maher L. A., Howell A. W., Redding J. S. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother. 1990;34(11):2075-2080.

   Not in our library10.1128/aac.34.11.2075 (opens in a new tab)

8. 9.

   Spika J. S., Facklam R. R., Plikaytis B. D., Oxtoby M. J. Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. The Pneumococcal Surveillance Working Group. J Infect Dis. 1991;163(6):1273-1278.

   Not in our library10.1093/infdis/163.6.1273 (opens in a new tab)

9. 10.

   Sutcliffe J., Tait-Kamradt A., Wondrack L. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother. 1996;40(8):1817-1824.

   Not in our library10.1128/aac.40.8.1817 (opens in a new tab)

1 more reference, whose wording the paper’s licence keeps private.

• Antimicrobial-Drug Use and Changes in Resistance in Streptococcus pneumoniae · 2000

  Not checked

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.